Clopidogrel and Genotyping

J Invasive Cardiol. 2015 Aug;27(8):E173-4.
No abstract available

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Acute Coronary Syndrome / genetics
  • Acute Coronary Syndrome / metabolism
  • Acute Coronary Syndrome / therapy*
  • Clopidogrel
  • Cytochrome P-450 CYP2C19 / genetics*
  • Drug Therapy, Combination
  • Gastrointestinal Hemorrhage* / chemically induced
  • Gastrointestinal Hemorrhage* / genetics
  • Gastrointestinal Hemorrhage* / prevention & control
  • Genotype
  • Humans
  • Omeprazole / therapeutic use
  • Percutaneous Coronary Intervention*
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / pharmacokinetics
  • Risk Factors
  • Stents
  • Ticlopidine / adverse effects
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / pharmacokinetics

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Cytochrome P-450 CYP2C19
  • Omeprazole
  • Ticlopidine